Close

Takeda Recognized as one of the Global 100 Most Sustainable Corporationsย for second consecutive year

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

94th CMEF to Bring Global Medical Device Industry Together in Beijing

BEIJING, Oct. 01, 2026 - The 94th China International...

Oncodesign Services and Nexus BioQuest Form Preclinical Partnership

Oncodesign Services and Nexus BioQuest have formed a partnership...

ACHEMA 2027 Strengthens India Process Industry Collaboration

DECHEMA, EEPC INDIA and Messe Frankfurt India brought together...
- Advertisement -

Takeda Pharmaceutical Company Limited ,is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index.

Takeda achieved this distinction for the second consecutive year and it is based on 14 key performance indicators, including energy productivity, innovation capacity, safety performance and leadership diversity.

Since 1781, Takeda has been committed to improving the future of healthcare. Inclusion in the Global 100 Index highlights the progress Takeda has made in its corporate responsibility efforts and sustainability planning.

โ€œTakeda is honored to be included among such distinguished global corporations again,โ€ said Haruhiko Hirate, Corporate Communications ๏ผ† Public Affairs Officer. โ€œFor Takeda, corporate social responsibility ๏ผˆCSR๏ผ‰ is rooted in putting the patient at the center of everything we do. While we continuously strive to improve our business processes, we are also proud to engage in activities that promote a sustainable society and reflect our commitment to being a good corporate citizen.โ€

In conducting its activities, Takeda adheres to internationally recognized guidelines, such as the United Nations Global Compactโ€™s 10 principles, and long-term international targets, such as the Sustainable Development Goals ๏ผˆSDGs๏ผ‰.

About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R๏ผ†D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R๏ผ†D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.

Additional information about Takeda is available through its CSR Data Book 2016, http://www.takeda.com/csr/reports/

Media Contacts:
Japanese Media
Tsuyoshi Tadaย 
TEL:๏ผ‹81๏ผ3๏ผ3278๏ผ2417
tsuyoshi.tada@takeda.com

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

94th CMEF to Bring Global Medical Device Industry Together in Beijing

BEIJING, Oct. 01, 2026 - The 94th China International...

Oncodesign Services and Nexus BioQuest Form Preclinical Partnership

Oncodesign Services and Nexus BioQuest have formed a partnership...

ACHEMA 2027 Strengthens India Process Industry Collaboration

DECHEMA, EEPC INDIA and Messe Frankfurt India brought together...

Onyx Scientific Boosts API Manufacturing Capacity in UK

Onyx Scientific, a global small molecule CDMO, is investing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป